Literature DB >> 3121672

Treatment of congenital pseudarthrosis with the Ilizarov technique.

G Fabry1, J Lammens, J Van Melkebeek, J Stuyck.   

Abstract

Four patients with congenital pseudarthrosis in neurofibromatosis were treated with percutaneous transosseous fixation according to the Ilizarov method. Three tibias were first treated unsuccessfully with a Sofield procedure. After application of the Ilizarov fixator, consolidation was obtained in two cases after 6 and 19 months, respectively. A fourth case consisted of a congenital pseudarthrosis of the ulna, primarily treated with the Ilizarov system, which showed advanced consolidation after 4 months.

Entities:  

Mesh:

Year:  1988        PMID: 3121672     DOI: 10.1097/01241398-198801000-00016

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  6 in total

1.  Reconstruction of bony defects using the Ilizarov "bone transport" technique. A preliminary report.

Authors:  J Lammens; G Fabry
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

Review 2.  Ilizarov treatment of congenital pseudarthrosis of the tibia: a multi-targeted approach using the Ilizarov technique.

Authors:  In Ho Choi; Tae-Joon Cho; Hyuk Ju Moon
Journal:  Clin Orthop Surg       Date:  2011-02-15

3.  Successful treatment of congenital pseudarthrosis of the tibia: still a challenge.

Authors:  K Bobotas; S N Lallos; V S Nikolaou; D S Kοrres; N E Efstathopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-02

4.  Epidemiology and treatment outcome of congenital pseudarthrosis of the tibia.

Authors:  Joachim Horn; Harald Steen; Terje Terjesen
Journal:  J Child Orthop       Date:  2013-01-18       Impact factor: 1.548

5.  Pseudoarthrosis of the ulna in neurofibromatosis. A report of four cases.

Authors:  N Maffulli; J A Fixsen
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

6.  Congenital pseudarthrosis of the tibia: Management and complications.

Authors:  Hitesh Shah; Marie Rousset; Federico Canavese
Journal:  Indian J Orthop       Date:  2012-11       Impact factor: 1.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.